Sun Pharmaceutical Industries Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is PANTOPRAZOLE SODIUM USP, with a corresponding US DMF Number 17090.
Remarkably, this DMF maintains an Active status since its submission on January 08, 2004, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of June 20, 2019, and payment made on June 17, 2019, indicating their dedication to facilitating drug approvals, Categorized as Type II